Aanjaay Industries Reports Non-Applicability of SEBI Regulation 32 for Q2 FY27
Kabra Drugs Ltd 路 Others (Uncategorized) 路 07 Nov 2026, 12:52 am
Aanjaay Industries Reports Non-Applicability of SEBI Regulation 32 for Q2 FY27 Aanjaay Industries Limited submitted an undertaking to BSE confirming that Regulation 32 of SEBI (LODR) Regulations, 2015 is not applicable for the quarter ended 30th Sep'26. Managing Director Nanjappan Aravind certified that the company did not raise funds through any public, rights, or preferential issues during the period, resulting in zero deviations or variations in fund utilization.
Original exchange filing (PDF)
More announcements from Kabra Drugs Ltd
- Financial Results for the quarter ended 30-September-2026. 路 07 Nov 2026
- Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting to .... 路 06 Nov 2026
- Scrutinizers Report 路 01 Oct 2026
- Proceedings of Annual General Meeting 路 30 Sept 2026
- Reg. 34 (1) of Annual Report for the financial year 2025-2026 路 09 Sept 2026
- Notice 37th Annual General Meeting of the Company 路 08 Sept 2026
- Appointment of Internal Auditor of the Company 路 03 Sept 2026
- Appointment of Secretarial Auditor of the Company 路 03 Sept 2026
